EVIO, Inc. Emphasises that its Divestment of Former Cannabis Testing Operations Occurred Over 45 Months Ago
Henderson, Nevada — February 18th, 2026 — EVIO, Inc. ("EVIO" or the "Company") is today providing an update to shareholders and market participants to emphasize that the Company's cannabis-testing operations were terminated over 45 months ago and therefore the Company cannot now be reasonably classified as a cannabis-related issuer.
EVIO has very recently become aware that certain third-party databases and monitoring services, including CRB Monitor, have erroneously continued to classify EVIO as a cannabis-related issuer based on Company business operation descriptions published in old public filings that are no longer relevant to the Company's current business operations and may create confusion for stakeholders, including financial intermediaries, that may cause economic damage to the Company and its future prospects.
Clarification Regarding 2022 Divestment and Discontinued Operations
As disclosed in the Company's quarterly report for December 31, 2025 (restated), during 2022 the Company discontinued operations of certain former subsidiaries and completed an asset sale in April 2022 related to its former cannabis testing footprint. In connection with that corporate restructuring, the Company's cannabis testing operations and related assets were divested and discontinued.
To ensure market materials accurately reflect this history and the Company's current posture, EVIO has reposted and updated its disclosure package to more clearly state in Note 1 of the Company's financials:
"During 2022, operations at C3 Labs, LLC were discontinued due to deteriorating market conditions and Greenhaus Analytical Labs performed an asset sale of its license, equipment and assets in April 2022. As a result of these actions the Company at that time ceased analytical testing for cannabis and cannabis products including hemp and CBD products and ceased to be a cannabis-related issuer at that time."
Removal of Legacy Revenue Recognition Language
In addition, the Company has removed legacy Note 2 disclosure language discussing revenue recognition practices specific to cannabis testing. That narrative was applicable to a prior operating period and does not reflect current revenue activity. EVIO's updated disclosure package is intended to reduce confusion by aligning accounting policy discussion with the Company's current operations.
Corporate Website Update
The Company also noted that a refreshed corporate website will be completed in the near future and is pending activation. EVIO expects the site to be made publicly accessible promptly after maintenance work is completed.
About EVIO, Inc.
EVIO, Inc. (OTC: EVIO) is a Nevada corporation working to reestablish itself as an active, fully reporting public company through consistent disclosure, transparency, and operational discipline. The Company is positioning its public-company platform to pursue technology-oriented business ventures and strategic opportunities.
Forward-Looking Statements
This release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include all statements that are not statements of historical fact regarding the intent, belief, or current expectations of the Company, its directors or its officers, including statements regarding product development status, intended system capabilities, licensing potential, timelines, and future plans. Words such as "may," "would," "will," "estimate," "can," "believe," "potential," "expect," "near," and similar expressions are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many beyond the Company's ability to control, and actual results may differ materially.
No Offer or Solicitation
This press release is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities.
Company Contact
EVIO, Inc.
Email: info@evioinc.com
Phone: +1 424-224-5358